| GTO ID | GTC1882 |
| Trial ID | NCT03494712 |
| Disease | Cardiovascular System Disease |
| Altered gene | miR-92a |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | S95010 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Safety, Tolerability and Pharmacokinetics of S 95010 After Single Escalating Intravenous Doses in Young Healthy Male Subjects. A Randomised, Doubleblind, Placebo-controlled, Monocentre, First-In-Human Study. |
| Year | 2018 |
| Country | Belgium |
| Company sponsor | Institut de Recherches Internationales Servier |
| Other ID(s) | CL1-95010-001|2017-004180-12 ( EudraCT Number ) |
| Vector information | |||
|
|||
| Cohort1: S 95010 | |||||||||
|
|||||||||
| Cohort2: Placebo | |||||||||
|
|||||||||